Sexual HIV/HSV-2 Risk Among Drug Users in New York City: An HIV Testing and Counseling Intervention

REFERENCES

• Abdul-Quader, A. S., Heckathorn, D. D., McKnight, C., Bramson, H., Nemeth, C., Sabin, K., (2006). Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study. Journal of Urban Health, 83(3), 459–476.
   PubMed Web of Science ®Google Scholar
• Anderson, L. A., & Dedrick, R. F. (1990). Development of the trust in physician scale: a measure to assess interpersonal trust in patient-physcian relationships. Psychological Reports, 67(3f), 1091–1100.
   PubMedGoogle Scholar
• Bjekic, M., Vlajinac, H., & Marinkovic, J. (1999). Sociopathologic behavior and repeated infection with venereal disease. Srpski Arhiv za Celokupno Lekarstvo, 127(7–8), 254–257.
   PubMedGoogle Scholar
• Boyer, C. B., Barrett, D. C., Peterman, T. A., & Bolan, G. (1997). Sexually transmitted disease (STD) and HIV risk in heterosexual adults attending a public STD clinic: evaluation of a randomized controlled behavioral risk-reduction intervention trial. AIDS, 11(3), 359–367.
   PubMedGoogle Scholar
• Celum, C., Wald, A., Hughes, J., Sanchez, J., Reid, S., Delany-Moretlwe, S., (2008). Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet, 371(9630), 2109–2119.
   PubMed Web of Science ®Google Scholar
• Celum, C., Wald, A., Lingappa, J. R., Magaret, A. S., Wang, R. S., Mugo, N., (2010). Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. New England Journal of Medicine, 362(5), 427–439.
   PubMed Web of Science ®Google Scholar
• Colón, H. M., Finlinson, H. A., Robles, R. R., Deren, S., Andía, J., Kang, S. Y., (2001). Joint drug purchases and drug preparation risk behaviors among Puerto Rican injection drug users. AIDS and Behavior, 5(1), 85–96.
   Google Scholar
• Corey, L., Wald, A., Celum, C. L., & Quinn, T. C. (2004). The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. Journal of Acquired Immune Deficiency Syndromes, 35(5), 435–445.
   PubMed Web of Science ®Google Scholar
• Dembo, R., Belenko, S., Childs, K., & Wareham, J. (2009). Drug use and sexually transmitted diseases among female and male arrested youths. Journal of Behavioral Medicine, 32(2), 129–141.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Arasteh, K., McKnight, C., Hagan, H., Perlman, D. C., & Semaan, S. (2011). Associations between herpes simplex virus type 2 and HCV with HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV. American Journal of Public Health, 101(7), 1277–1283.
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Hagan, H., Arasteh, K., McKnight, C., Perlman, D., & Friedman, S. R. (2007). Herpes simplex virus-2 and HIV among noninjecting drug users in New York City. Sexually Transmitted Disease, 34(11), 923–927.
   PubMed Web of Science ®Google Scholar
• Dickerson, M. C., Johnston, J., Delea, T. E., White, A., & Andrews, E. (1996). The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus: an application of the Bradford Hill criteria. Sexually Transmitted Diseases, 23(5), 429–440.
   PubMed Web of Science ®Google Scholar
• Dunne, E. F., Whitehead, S., Sternberg, M., Thepamnuay, S., Leelawiwat, W., McNicholl, J. M., (2008). Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand. Journal of Acquired Immune Deficiency Syndromes, 49(1), 77–83.
   PubMed Web of Science ®Google Scholar
• Elwy, A. R., Hart, G. J., Hawkes, S., & Petticrew, M. (2002). Effectiveness of interventions to prevent sexually transmitted infections and human immunodeficiency virus in heterosexual men: a systematic review. Archives of Internal Medicine, 162(16), 1818–1830.
   PubMed Web of Science ®Google Scholar
• Feist-Price, S., Logan, T., Leukefeld, C., Moore, C. L., & Ebreo, A. (2003). Targeting HIV prevention on African American crack and injection drug users. Substance Use & Misuse, 38(9), 1259–1284.
   PubMed Web of Science ®Google Scholar
• Fleming, D. T., & Wasserheit, J. N. (1999). From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sexually Transmitted Infections, 75(1), 3–17.
   PubMed Web of Science ®Google Scholar
• Ford, K., Wirawan, D. N., Reed, B. D., Muliawan, P., & Wolfe, R. (2002). The Bali STD/AIDS Study: evaluation of an intervention for sex workers. Sexually Transmitted Diseases, 29(1), 50–58.
   PubMed Web of Science ®Google Scholar
• Freeman, E. E., Weiss, H. A., Glynn, J. R., Cross, P. L., Whitworth, J. A., & Hayes, R. J. (2006). Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS, 20(1), 73–83.
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Lieb, S., Tempalski, B., Cooper, H., Keem, M., Friedman, R., (2005). HIV among injection drug users in large US metropolitan areas, 1998. Journal of Urban Health, 82(3), 434–445.
   PubMed Web of Science ®Google Scholar
• Golub, S. A., Rosenthal, L., Cohen, D. E., & Mayer, K. H. (2008). Determinants of high-risk sexual behavior during post-exposure prophylaxis to prevent HIV infection. AIDS and Behavior, 12(6), 852–859.
   PubMedGoogle Scholar
• Gottlieb, S. L., Douglas, J. M., Schmid, D. S., Bolan, G., Iatesta, M., Malotte, C. K., (2002). Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitteddisease clinics. Journal of Infectious Diseases, 186(10), 1381–1389.
   PubMedGoogle Scholar
• Gyarmathy, V. A., Neaigus, A., Miller, M., Friedman, S. R., & Des Jarlais, D. C. (2002). Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. Journal of Acquired Immune Deficiency Syndromes, 30(4), 448–456.
   PubMed Web of Science ®Google Scholar
• Hagan, H., Campbell, J., Thiede, H., Strathdee, S., Ouellet, L., Kapadia, F., (2006). Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Reports, 121(6), 710–719.
   PubMed Web of Science ®Google Scholar
• Hagan, H., Campbell, J. V., Thiede, H., Strathdee, S. A., Ouellet, L., Latka, M., (2007). Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior. Drug and Alcohol Dependence, 91(1 Suppl.), S48–S55.
   Google Scholar
• Hagan, H., Jenness, S. M., Wendel, T., Murrill, C. R., Neaigus, A., & Gelpi-Acosta, C. (2010). Herpes simplex virus type 2 associated with HIV infection among New York heterosexuals living in high-risk areas. International Journal of STD & AIDS, 21(8), 580–583.
   PubMedGoogle Scholar
• Hagan, H., Perlman, D. C., & Des Jarlais, D. C. (2011). Sexual risk and HIV infection among drug users in New York City: a pilot study. Substance Use & Misuse, 46(2–3), 201–207.
   PubMed Web of Science ®Google Scholar
• Hops, H., Ozechowski, T. J., Waldron, H. B., Davis, B., Turner, C. W., Brody, (2011). Adolescent health-risk sexual behaviors: effects of a drug abuse intervention. AIDS and Behavior, 15(8), 1664–1676.
   PubMed Web of Science ®Google Scholar
• Jenness, S. M., Murrill, C. S., Liu, K. L., Wendel, T., Begier, E., & Hagan, H. (2009). Missed opportunities for HIV testing among high-risk heterosexuals. Sexually Transmitted Disease, 36(11), 704–710.
   PubMed Web of Science ®Google Scholar
• Jones, D. L., Irwin, K. L., Inciardi, J., Bowser, B., Schilling, R., Word, C., (1998). The high-risk sexual practices of crack-smoking sex workers recruited from the streets of three American cities: the Multicenter Crack Cocaine and HIV Infection Study Team. Sexually Transmitted Disease, 25(4), 187–193.
   PubMed Web of Science ®Google Scholar
• Kamb, M. L., Dillon, B. A., Fishbein, M., & Willis, K. L. (1996). Quality assurance of HIV prevention counseling in a multi-center randomized controlled trial: Project RESPECT Study Group. Public Health Reports, 111(1 Suppl.), 99–107.
   PubMedGoogle Scholar
• Kamb, M. L., Fishbein, M., Douglas, J. M., Jr., Rhodes, F., Rogers, J., Bolan, G., (1998). Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. JAMA, 280(13), 1161–1167.
   PubMed Web of Science ®Google Scholar
• Leone, P. (2005). Reducing the risk of transmitting genital herpes: advances in understanding and therapy. Current Medical Research & Opinion, 21(10), 1577–1582.
   PubMed Web of Science ®Google Scholar
• Logan, T. K., Cole, J., & Leukefeld, C. (2002). Women, sex, and HIV: social and contextual factors, meta-analysis of published interventions, and implications for practice and research. Psychology Bulletin, 128(6), 851–885.
   PubMed Web of Science ®Google Scholar
• Malow, R. M., West, J. A., Corrigan, S. A., Pena, J. M., & Cunningham, S. C. (1994). Outcome of psychoeducation for HIV risk reduction. AIDS Education and Prevention, 6(2), 113–125.
   PubMed Web of Science ®Google Scholar
• McCoy, C. B., Metsch, L. R., Comerford, M., Zhao, W., Coltes, A. J., & Messiah, S. E. (2005). Trends of HIV risk behaviors in a cohort of injecting drug users and their sex partners in Miami, Florida, 1988–1998. AIDS and Behavior, 9(2), 187–199.
   PubMed Web of Science ®Google Scholar
• McKirnan, D., Houston, E., & Tolou-Shams, M. (2007). Is the Web the culprit? Cognitive escape and Internet sexual risk among gay and bisexual men. AIDS and Behavior, 11(1), 151–160.
   PubMed Web of Science ®Google Scholar
• Miller, W. R., Rollnick, S., & Conforti, K. (2002). Motivational interviewing: preparing people for change (2nd ed.): Guilford Press.
   Google Scholar
• Neaigus, A., Miller, M., Friedman, S. R., & Des Jarlais, D. C. (2001). Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus. Journal of Infectious Diseases, 184(3), 359–363.
   PubMed Web of Science ®Google Scholar
• New York City Department of Health and Mental Hygiene (2006). Take care: Central Harlem. New York, NY: Division of Epidemiology, Bureau of Epidemiology.
   Google Scholar
• New York City Department of Health and Mental Hygiene (2008). 4th Quarter 2008 Quarterly Report. New York, NY: Bureau of Sexually Transmitted Disease Control.
   Google Scholar
• New York City Department of Health and Mental Hygiene (2010). 3rd Quarter 2010 Quarterly Report. New York, NY: Bureau of Sexually Transmitted Disease Control.
   Google Scholar
• New York City Department of City Planning (2011). NYC 2010 Results from the 2010 census: Population growth and race/hispanic composition. New York, NY: Population Division.
   Google Scholar
• Ompad, D. C., Friedman, S. R., Hwahng, S. J., Nandi, V., Fuller, C. M., & Vlahov, D. (2011). HIV risk behaviors among young drug using women who have sex with women (WSWs) in New York City. Substance Use & Misuse, 46(2–3), 274–284.
   PubMed Web of Science ®Google Scholar
• Ostrow, D. G., Silverberg, M. J., Cook, R. L., Chmiel, J. S., Johnson, L., Li, X., (2008). Prospective study of attitudinal and relationship predictors of sexual risk in the multicenter AIDS cohort study. AIDS and Behavior, 12(1), 127–138.
   PubMedGoogle Scholar
• Perlman, D., Kottiri, B. J., Salomon, N., & Friedman, S. R. (2009). Sexually transmitted diseases in drug users. In J. M. Zenilman (Ed.), Sexually transmitted diseases and reproductive health. Philadelphia, PA: Saunders, W.B.
   Google Scholar
• Plitt, S. S., Sherman, S. G., Strathdee, S. A., & Taha, T. E. (2005). Herpes simplex virus 2 and syphilis among young drug users in Baltimore, Maryland. Sexually Transmitted Infections, 81(3), 248–253.
   PubMedGoogle Scholar
• Ross, M. W., Hwang, L. Y., Leonard, L., Teng, M., & Duncan, L. (1999). Sexual behaviour, STDs and drug use in a crack house population. International Journal of STD & AIDS, 10(4), 224–230.
   PubMed Web of Science ®Google Scholar
• Rotheram-Borus, M. J., Rhodes, F., Desmond, K., & Weiss, R. E. (2010). Reducing HIV risks among active injection drug and crack users: the safety counts program. AIDS and Behavior, 14(3), 658–668.
   PubMed Web of Science ®Google Scholar
• Røttingen, J. A., Cameron, D. W., & Garnett, G. P. (2001). A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sexually Transmitted Diseases, 28(10), 579–597.
   Google Scholar
• Salomon, N., Perlman, D. C., Friedmann, P., Perkins, M. P., Ziluck, V., Jarlais, D. C. D., (1999). Knowledge of tuberculosis among drug users: relationship to return rates for tuberculosis screening at a syringe exchange. Journal of Substance Abuse Treatment, 16(3), 229–235.
   PubMedGoogle Scholar
• Schillinger, J. A., McKinney, C. M., Garg, R., Gwynn, R. C., White, K., Lee, F., (2008). Seroprevalence of herpes simplex virus type 2 and characteristics associated with undiagnosed infection: New York City, 2004. Sexually Transmitted Diseases, 35(6), 599–606.
   PubMedGoogle Scholar
• Semaan, S., Des Jarlais, D. C., Sogolow, E., Johnson, W. D., Hedges, L. V., Ramirez, G., (2002). A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. Journal of Acquired Immune Deficiency Syndromes, 30(1 Suppl.), S73–S93.
   PubMedGoogle Scholar
• Strathdee, S. A., Galai, N., Safaiean, M., Celentano, D. D., Vlahov, D., Johnson, L., (2001). Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Archives of Internal Medicine, 161(10), 1281–1288.
   PubMed Web of Science ®Google Scholar
• Thomas, J. C., Schoenbach, V. J., Weiner, D. H., Parker, E. A., & Earp, J. A. (1996). Rural gonorrhea in the southeastern United States: a neglected epidemic? American Journal of Epidemiology, 143(3), 269–277.
   PubMedGoogle Scholar
• Tronstein, E., Johnston, C., Huang, M. L., Selke, S., Magaret, A., Warren, T., (2011). Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA, 305(14), 1441–1449.
   PubMed Web of Science ®Google Scholar
• Tross, S., Campbell, A. N., Cohen, L. R., Calsyn, D., Pavlicova, M., Miele, G. M., (2008). Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network Trial. Journal of Acquired Immune Deficiency Syndromes, 48(5), 581–589.
   PubMed Web of Science ®Google Scholar
• Tyndall, M., Patrick, D., Spittal, P., Li, K., O'Shaughnessy, M., & Schechter, M. (2002). Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control. Sexually Transmitted Infections, 78(1 Suppl.), i170–i175.
   Google Scholar
• Van den Hoek, A. (1997). STD control in drug users and street youth. Genitourinary Medicine, 73(4), 240–244.
   PubMedGoogle Scholar
• van Empelen, P., Kok, G., van Kesteren, N., van den Borne, B., Bos, A. E. R., & Schaalma, H. P. (2003). Effective methods to change sex-risk among drug users: a review of psychosocial interventions. Social Science & Medicine, 57(9), 1593–1608.
   PubMed Web of Science ®Google Scholar
• Wawer, M. J., Gray, R. H., Sewankambo, N. K., Serwadda, D., Li, X., Laeyendecker, O., (2005). Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. Journal of Infectious Diseases, 191(9), 1403–1409.
   PubMed Web of Science ®Google Scholar
• Whitley, R. J., & Roizman, B. (2001). Herpes simplex virus infections. Lancet, 357(9267), 1513–1518.
   PubMed Web of Science ®Google Scholar
• Williams, M., Bowen, A., Atkinson, J. S., Nilsson-Schonnesson, L., Diamond, P. M., Ross, M. W., (2012). An assessment of brief group interventions to increase condom use by heterosexual crack smokers living with HIV infection. AIDS Care, 24(2), 220–231.
   PubMed Web of Science ®Google Scholar
• Xu, F., Sternberg, M. R., Kottiri, B. J., McQuillan, G. M., Lee, F. K., Nahmias, A. J., (2006). Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA: The Journal of the American Medical Association, 296(8), 964–973.
   PubMed Web of Science ®Google Scholar